Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sorrento Therpt (SRNE)

14.09   -4.73 (-25.13%) 08-11 16:00
Open: 18.1 Pre. Close: 18.82
High: 18.3258 Low: 12.61
Volume: 170,721,262 Market Cap: 3,410M
Sorrento Therapeutics, Inc., a clinical stage biopharma company, develops therapies for cancer, autoimmune, inflammatory, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as bispecific antibody approaches. It also offers Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system. In addition, the company's clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft-versus-host diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.351 - 18.448 18.448 - 18.53
Low: 12.449 - 12.526 12.526 - 12.591
Close: 13.95 - 14.095 14.095 - 14.218

Technical analysis

as of: 2020-08-11 4:36:03 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 22.65     One year: 26.45
Support: Support1: 11.19    Support2: 6.12
Resistance: Resistance1: 19.39    Resistance2: 22.65
Pivot: 10.73
Moving Average: MA(5): 14.95     MA(20): 9.90
MA(100): 5.22     MA(250): 3.63
MACD: MACD(12,26): 2.27     Signal(9): 1.56
Stochastic oscillator: %K(14,3): 81.18     %D(3): 87.79
RSI: RSI(14): 63.32
52-week: High: 19.39  Low: 1.39  Change(%): 587.3
Average Vol(K): 3-Month: 4433409  10-Days: 8906101

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SRNE has closed below upper band by 25.6%. Bollinger Bands are 409.9% wider than normal. The large width of the bands suggest high volatility as compared to SRNE's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Tue, 11 Aug 2020
Why Sorrento Therapeutics Stock Has Skyrocketed 1,000% Since the Market Crash - Nasdaq

Tue, 11 Aug 2020
SRNE Stock Forecast: Sorrento Therapeutics to extend rally amid broader COVID-19 portfolio - FXStreet

Mon, 10 Aug 2020
Sorrento adds to COVID-19-stoked rally, shares up 24% - Seeking Alpha

Tue, 04 Aug 2020
3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock - InvestorPlace

Wed, 29 Jul 2020
Sorrento jumps 4.5% after licensing rapid COVID-19 test from Columbia - Seeking Alpha

Tue, 28 Jul 2020
Vision of a Covid-19 Breakthrough Makes Sorrento Therapeutics Stock a Buy -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 210
Shares Float (M) 145
% Held by Insiders 34.21
% Held by Institutions 17.86
Shares Short (K) 50,080
Shares Short P. Month (K) 37,060

Stock Financials

EPS -1.950
EPS Est This Year -1.070
EPS Est Next Year -0.650
Book Value (p.s.) 0.510
Profit Margin
Operating Margin -577.03
Return on Assets (ttm) -20.8
Return on Equity (ttm) -337.4
Qtrly Rev. Growth 25.7
Gross Profit (p.s.) -0.418
Sales Per Share 0.157
EBITDA (p.s.) -0.858
Qtrly Earnings Growth
Operating Cash Flow (M) -167
Levered Free Cash Flow (M) -115

Stock Valuations

PE Ratio -7.23
PEG Ratio
Price to Book value 27.63
Price to Sales 89.50
Price to Cash Flow -17.67

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.